Biotech Startups

Dark Blue Therapeutics develops novel medicines for cancer through integrated drug discovery combining internal expertise with academic partnerships. The company focuses on identifying transformative therapeutic approaches across multiple cancer mechanisms.

1 investor

Darwin Bioprospecting converts microbial diversity into industrial solutions, leveraging microbial strains and genomics for applications across health, nutrition, and biosolutions.

1 investor

DataHow develops AI-powered design of experiments software for bioprocess development, using hybrid modeling to combine mechanistic knowledge with machine learning to reduce experimental cycles and accelerate process understanding.

1 investor

Datar Cancer Genetics is a healthcare company focused on cancer diagnostics and genetics. The company provides statutory investor relations information and annual reports for shareholders.

1 investor

Daxiang Bio develops organ-on-chip systems that recreate organ physiology and pathology in vitro to enable drug response prediction and medical research. The technology is applied in pharmaceutical development and biomedical research.

1 investor

The page is a bioMérieux blog article about tracking a Cyclospora cayetanensis outbreak in the United States, referencing its clinical diagnostic and wastewater surveillance products for community health and medical professionals.

1 investor

DBV Technologies develops the VIASKIN® patch, a non-invasive, skin-based immunotherapy technology for treating food allergies and other immunological disorders. The company is investigating applications including allergy treatment and vaccine delivery through epicutaneous immunotherapy.

1 investor

Duoseq offers a comprehensive cancer genomics assay that profiles both DNA and RNA from a single sample in one preparation, delivering mutations, expression, fusions, and clonotype data with sample-to-report turnaround in about two days. It is built for on-site lab use with robotic workflow automation and integrates directly with EPIC and other EHR systems.

1 investor

DealForma provides a data platform and analyst support for biopharma business development teams to research partnerships, deals, funding trends, and therapeutic areas. The service combines curated company profiles from thousands of industry sources with direct analyst assistance for deal preparation and strategic research.

1 investor

Decade develops targeted cancer therapies using AI and high-throughput data analysis to match treatments to individual patients' tumor molecular profiles.

1 investor

Decade Energy provides electrification solutions for mobility and fleet depots, including grid upgrades, battery storage, charging infrastructure, and energy optimization software. It focuses on securing long-term grid capacity for electric truck and fleet depots across Europe.

1 investor

Regeneron is a biopharmaceutical company that discovers, develops, and commercializes medicines using proprietary technologies and genetic databases. The company serves patients with serious diseases across oncology, immunology, ophthalmology, and other therapeutic areas.

1 investor

Deciphera is a pharmaceutical company focused on developing treatments for people living with cancer. Its work centers on oncology drug development and support for patient communities.

1 investor

1 investor

DecisionRx is a health technology company focused on medication decision support and pharmacy operations within the diagnostics and pharmacogenomics space. Its leadership brings experience from diagnostics labs, health insurers, and healthcare technology firms.

1 investor

deCODE analyzes and interprets the human genome to identify genetic risk factors for common diseases including cardiovascular disease and cancer. The company serves pharmaceutical and research organizations through genomic discovery and analysis.

1 investor

Decode Love is a pilot program that analyzes a participant's DNA (SNPs) alongside a psychology survey to produce a personalized report scoring five clusters of emotional and personality traits. It positions this as a self-discovery and relationship self-awareness tool for individuals, framed around genetics and psychology rather than dating or matchmaking.

1 investor

Decoy Smart develops biological pest control solutions for animal health and agriculture, targeting parasites such as ticks and fleas in cattle, horses and pets, beetles in poultry farms, and the Varroa mite affecting bees. The company applies science-based biological methods as alternatives for controlling pests in livestock and farming environments.

1 investor

Deepflare provides an AI platform for antigen design that predicts T-cell immunogenicity to accelerate vaccine and therapeutic discovery. The platform serves biotech companies and researchers developing viral and cancer treatments.

1 investor

Deep MedChem develops CHEESE, a family of AI products for drug discovery that let researchers search, predict, and explore 2D, 3D shape, electrostatic, and activity similarity across 40T+ molecules, deployable on cloud or on-premises. It serves pharmaceutical and biotech drug discovery teams and is a spin-off from The MAMA AI and i&i Prague connected to the IOCB medicinal chemistry institute in Europe.

1 investor

Deep Root Biolabs develops a biomolecule delivery solution that enhances plants to extract pollutants from soil and concentrate critical minerals, serving agriculture, mineral reclamation, and remediation applications. The technology uses plant-based biomolecules as a non-GMO approach to improve plant performance for environmental and agricultural purposes.

1 investor

Deffai is an AI-native regulatory affairs platform that helps life sciences companies prepare and strengthen FDA submissions using domain-specific AI built on review patterns and guidances. It targets biotech and medical device firms working on areas such as cell and gene therapy, vaccines, oncology, and combination products, and is staffed by former FDA reviewers and decision-makers.

1 investor

Definigen manufactures iPSC-derived human hepatocytes for drug discovery and disease modeling. The product line supports preclinical toxicity testing, metabolism studies, and disease research in pharmaceutical development.

1 investor

1 investor